Addex Therapeutics Ltd Stock
Stocks
ADXN
CH0029850754
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Swiss Exchange
12:37:27 29/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0190 CHF | -12.84% |
|
-16.67% | -65.70% |
| 09-28 | Addex Therapeutics Ltd, H1 2026 Earnings Call, Sep 28, 2026 | |
| 09-28 | Addex Therapeutics Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 2.6M 3.13M 2.75M 2.36M 4.43M 300M 4.46M 31.14M 12.03M 153M 11.74M 11.49M 492M | P/E 2024 |
0.8x | P/E 2025 | -0.88x |
|---|---|---|---|---|---|
| Enterprise Value | 997K 1.2M 1.05M 905K 1.7M 115M 1.71M 11.94M 4.61M 58.73M 4.5M 4.4M 189M | EV / Sales 2024 |
5.67x | EV / Sales 2025 | 28.1x |
| Free-Float |
43.94% | Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| ADXN | Delayed | |
CBOE
| 0QNV | Real-time | |
|
Boerse Muenchen
| APE | Real-time | |
|
Deutsche Boerse AG
| APE | Delayed | |
|
Börse Stuttgart
| APE | Delayed |
Last Transcript: Addex Therapeutics Ltd
| 1 day | -12.84% | ||
| 1 week | -16.67% | ||
| Current month | -29.10% | ||
| 1 month | -29.10% | ||
| 3 months | -57.01% | ||
| 6 months | -56.82% | ||
| Current year | -65.70% |
| 1 week | 0.02 |  | 0.03 |
| 1 month | 0.02 | | 0.03 |
| Current year | 0.02 | | 0.07 |
| 1 year | 0.02 | | 0.07 |
| 3 years | 0.02 | | 0.26 |
| 5 years | 0.02 | | 1.5 |
| 10 years | 0.02 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tim Dyer
CEO | Chief Executive Officer | 58 | 01/06/2013 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 40 | 01/06/2017 |
Roger Mills
CTO | Chief Tech/Sci/R&D Officer | 69 | 28/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Lawton
CHM | Chairman | 77 | - |
Tim Dyer
BRD | Director/Board Member | 58 | 01/01/2015 |
Ray Hill
BRD | Director/Board Member | 81 | 12/05/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/09/26 | Issuer sale | Chief Technology Officer | -885,674 | 0.4051% | ||
| 02/09/26 | Issuer sale | Director | -539,122 | 0.2466% | ||
| 02/09/26 | Issuer sale | Chief Financial Officer | -1,205,816 | 0.5515% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.84% | -16.67% | -68.54% | -71.12% | 3.13M | |
| +0.46% | +4.16% | +12.77% | +37.73% | 49.06B | |
| +0.22% | +0.40% | +50.91% | +37.06% | 44.6B | |
| -1.58% | +4.66% | +359.34% | +614.38% | 43.24B | |
| +1.70% | +0.36% | +12.56% | +99.27% | 41.73B | |
| +0.51% | -1.71% | +5.18% | +46.87% | 29.93B | |
| -0.48% | -1.32% | +23.98% | +150.01% | 17.19B | |
| +0.08% | +9.03% | +8.41% | - | 15.35B | |
| -2.01% | -2.25% | +26.94% | +44.26% | 15.54B | |
| +1.97% | -3.17% | - | - | 15.11B | |
| Average | -1.19% | +1.49% | +47.95% | +119.81% | 27.18B | |
| Weighted average by Cap. | +0.16% | +2.26% | +78.22% | +161.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 410K 493K 434K 372K 698K 47.33M 703K 4.91M 1.9M 24.15M 1.85M 1.81M 77.61M | 173K 208K 183K 157K 294K 19.95M 296K 2.07M 799K 10.18M 780K 763K 32.72M |
| Net income | 7.06M 8.48M 7.46M 6.4M 12.02M 814M 12.09M 84.48M 32.63M 416M 31.85M 31.16M 1.34B | -6.73M -8.09M -7.12M -6.1M -11.46M -777M -11.53M -80.56M -31.11M -396M -30.37M -29.72M -1.27B |
| Net Debt | -3.3M -3.97M -3.49M -2.99M -5.62M -381M -5.65M -39.51M -15.26M -194M -14.9M -14.57M -625M | -1.6M -1.93M -1.7M -1.45M -2.73M -185M -2.75M -19.2M -7.42M -94.47M -7.24M -7.08M -304M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | CHF 0.0190 | -12.84% | 743,167 |
| 28/09/26 | CHF 0.0218 | -11.38% | 1,690,862 |
| 25/09/26 | CHF 0.0246 | +0.82% | 2,299,711 |
| 24/09/26 | CHF 0.0244 | +2.52% | 857,931 |
| 23/09/26 | CHF 0.0238 | +4.39% | 304,169 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ADXN Stock
Select your edition
All financial news and data tailored to specific country editions
